Filing Details
- Accession Number:
- 0000950170-24-017084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-20 16:05:37
- Reporting Period:
- 2024-02-15
- Accepted Time:
- 2024-02-20 16:05:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1654151 | Deciphera Pharmaceuticals Inc. | DCPH | Pharmaceutical Preparations (2834) | 200299725 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1852595 | Jama Pitman | C/O Deciphera Pharmaceuticals, Inc. 200 Smith Street Waltham MA 02451 | Svp, Chief Development Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-15 | 9,725 | $0.00 | 60,298 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2024-02-15 | 10,000 | $0.00 | 70,298 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-02-16 | 2,267 | $15.62 | 68,031 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-02-15 | 38,900 | $0.00 | 38,900 | $15.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 38,900 | 2034-02-14 | No | 4 | A | Direct |
Footnotes
- The reporting person was awarded 9,725 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. These RSUs shall vest in three equal installments on each of February 15, 2025, February 15, 2026 and February 15, 2027.
- The reporting person was awarded 10,000 RSUs. These RSUs shall vest in two equal annual installments on each of February 15, 2025 and February 15, 2026.
- This sale was to cover tax liabilities in the vesting of RSUs.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.6175 to $15.6177, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in equal monthly installments over four years, beginning on March 15, 2024.
Billionaire Hedge Funds
